Biotechnology Assets S.A. (BST) — Cash Flow Quality Index
Biotechnology Assets S.A. (BST) has a Cash Flow Quality Index of -0.32x as of June 2023. Operating cash flow of €-935.60K is below net income of €2.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore BST asset base for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotechnology Assets S.A. Cash Flow Quality Index (2014–2023)
Historical Cash Flow Quality Index for Biotechnology Assets S.A. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Biotechnology Assets S.A. (BST) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Biotechnology Assets S.A. (2014–2023)
Year-by-year earnings quality comparison for Biotechnology Assets S.A.. For live market cap and the full company financial profile, see Biotechnology Assets S.A. market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.02x | €47.74K | €2.32 Million | ▲ +105.1% |
| 2014 | -0.40x | €-303.79K | €756.27K | — |